BRD4 inhibition, by preventing RNA Pol II loading, blunts the growth of YAP/TAZ-addicted breast tumors and YAP-driven liver tumors, and also rescues chemosensitivity in drug-resistant melanomas [37]. The gene discussed is WWTR1; the disease is melanoma.